Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats

Life Sciences

Volumn 135, Issue , 2015, Pages 43-48

  Bai, Yufeng ^a   An, Ruihua ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Erectile dysfunction; NO cGMP; Reactive oxygen species; Resveratrol; Superoxide anion

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; MESSENGER RNA; NEURONAL NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE V; REACTIVE OXYGEN METABOLITE; RESVERATROL; SILDENAFIL; SUPEROXIDE; TESTOSTERONE; ANTIOXIDANT; NOS1 PROTEIN, RAT; NOS3 PROTEIN, RAT; PHOSPHODIESTERASE V INHIBITOR; PIPERAZINE DERIVATIVE; PURINE DERIVATIVE; STILBENE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; ERECTILE DYSFUNCTION; GLUCOSE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TESTOSTERONE BLOOD LEVEL; TREATMENT DURATION; ANIMAL; BLOOD PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SECOND MESSENGER;

RATTUS;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; ERECTILE DYSFUNCTION; MALE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; RATS; SECOND MESSENGER SYSTEMS; STILBENES; SULFONAMIDES;

EID: 84934892621     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2015.04.020     Document Type: Article

References (36)

1. G.J. Ahn, H.K. Chung, C.H. Lee, K.K. Kang, and B.O. Ahn Increased expression of the nitric oxide synthase gene and protein in corpus cavernosum by repeated dosing of udenafil in a rat model of chemical diabetogenesis Asian J. Androl. 11 2009 435 442
2. O. Alexopoulou, J. Jamart, D. Maiter, M.P. Hermans, R. De Hertogh, and P. De Nayer Erectile dysfunction and lower androgenicity in type 1 diabetic patients Diabete Metab. 27 2001 329 336
3. J. Angulo, R. Gonzalez-Corrochano, P. Cuevas, A. Fernandez, J.M. La Fuente, and F. Rolo Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with erectile dysfunction in human corpus cavernosum and penile arteries J. Sex Med. 7 2010 758 768
4. A.L. Burnett, C.J. Lowenstein, D.S. Bredt, T.S. Chang, and S.H. Snyder Nitric oxide: a physiologic mediator of penile erection Science 257 1992 401 403
5. N. Caretta, A. Ferlin, P.F. Palego, and C. Foresta Erectile dysfunction in aging men: testosterone role in therapeutic protocols J. Endocrinol. Investig. 28 2005 108 111
6. C.C. Carson, A.L. Burnett, L.A. Levine, and A. Nehra The efficacy of sildenafil citrate (Viagra) in clinical populations: an update Urology 60 2002 12 27
7. J.J. Cartledge, I. Eardley, and J.F. Morrison Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes BJU Int. 87 2001 394 401
8. T.C. Chi, W.P. Chen, T.L. Chi, T.F. Kuo, S.S. Lee, and J.T. Cheng Phosphatidylinositol-3-kinase is involved in the antihyperglycemic effect induced by resveratrol in streptozotocin-induced diabetic rats Life Sci. 80 2007 1713 1720
9. W.F. Chiou, H.K. Liu, and C.W. Juan Abnormal protein expression in the corpus cavernosum impairs erectile function in type 2 diabetes BJU Int. 105 2010 674 680
10. G. Corona, A.M. Isidori, J. Buvat, A. Aversa, G. Rastrelli, and G. Hackett Testosterone supplementation and sexual function: a meta-analysis study J. Sex Med. 11 2014 1577 1592
11. T.M. Dao, A. Waget, P. Klopp, M. Serino, C. Vachoux, and L. Pechere Resveratrol increases glucose induced GLP-1 secretion in mice: a mechanism which contributes to the glycemic control PLoS One 6 2011 e20700
12. S. Fabris, F. Momo, G. Ravagnan, and R. Stevanato Antioxidant properties of resveratrol and piceid on lipid peroxidation in micelles and monolamellar liposomes Biophys. Chem. 135 2008 76 83
13. S. Fukuhara, A. Tsujimura, H. Okuda, K. Yamamoto, T. Takao, and Y. Miyagawa Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings J. Sex Med. 8 2011 1061 1071
14. S. Gur, T.C. Peak, P.J. Kadowitz, S.C. Sikka, and W.J. Hellstrom Review of erectile dysfunction in diabetic animal models Curr. Diabetes Rev. 10 2014 61 73
15. L.S. Hakim, and I. Goldstein Diabetic sexual dysfunction Endocrinol. Metab. Clin. N. Am. 25 1996 379 400
16. K. Hatzimouratidis Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence Clin. Interv. Aging 1 2006 403 414
17. K. Hatzimouratidis, and D.G. Hatzichristou Phosphodiesterase type 5 inhibitors: unmet needs Curr. Pharm. Des. 15 2009 3476 3485
18. H. Hirata, K. Kawamoto, N. Kikuno, T. Kawakami, K. Kawakami, and S. Saini Restoring erectile function by antioxidant therapy in diabetic rats J. Urol. 182 2009 2518 2525
19. M.L. Isidro Sexual dysfunction in men with type 2 diabetes Postgrad. Med. J. 88 2012 152 159
20. H.R. Jin, W.J. Kim, J.S. Song, S. Piao, M.J. Choi, and M. Tumurbaatar Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse Diabetes 60 2011 969 980
21. M.E. Juan, E. Gonzalez-Pons, T. Munuera, J. Ballester, J.E. Rodriguez-Gil, and J.M. Planas trans-Resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats J. Nutr. 135 2005 757 760
22. M. Kitada, S. Kume, N. Imaizumi, and D. Koya Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway Diabetes 60 2011 634 643
23. H.D. Langtry, and A. Markham Sildenafil: a review of its use in erectile dysfunction Drugs 57 1999 967 989
24. L.S. Malavige, and J.C. Levy Erectile dysfunction in diabetes mellitus J. Sex Med. 6 2009 1232 1247
25. F.J. Miller Jr., D.D. Gutterman, C.D. Rios, D.D. Heistad, and B.L. Davidson Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis Circ. Res. 82 1998 1298 1305
26. J.L. Rains, and S.K. Jain Oxidative stress, insulin signaling, and diabetes Free Radic. Biol. Med. 50 2011 567 575
27. N. Shukla, G. Rossoni, M. Hotston, A. Sparatore, P. Del Soldato, and V. Tazzari Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats BJU Int. 103 2009 1522 1529
28. C. Silan The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats Biol. Pharm. Bull. 31 2008 897 902
29. H.C. Su, L.M. Hung, and J.K. Chen Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats Am. J. Physiol. Endocrinol. Metab. 290 2006 E1339 E1346
30. T. Szkudelski, and K. Szkudelska Anti-diabetic effects of resveratrol Ann. N. Y. Acad. Sci. 1215 2011 34 39
31. A. Tuncayengin, H. Biri, M. Onaran, I. Sen, O. Tuncayengin, and F. Polat Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction Int. J. Androl. 26 2003 250 254
32. M.F. Usta, M. Kendirci, S. Gur, N.A. Foxwell, T.J. Bivalacqua, and S. Cellek The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin-induced diabetic rats: preventive versus curative treatment J. Sex Med. 3 2006 242 250 discussion 50-2
33. J. Yang, T. Wang, K. Rao, Y. Zhan, R.B. Chen, and Z. Liu S-allyl cysteine restores erectile function through inhibition of reactive oxygen species generation in diabetic rats Andrology 1 2013 487 494
34. W. Yu, Z. Wan, X.F. Qiu, Y. Chen, and Y.T. Dai Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats Asian J. Androl. 15 2013 646 651
35. X.M. Zhang, P.H. Shi, S.H. Cao, H.J. Yu, J. Azad, and S.C. Ling Expression changes of transforming growth factor-beta1 and thrombospondin-1 in cavernous tissues of diabetic rats Urol. Int. 84 2010 221 225
36. F. Zhou, G.Y. Li, Z.Z. Gao, J. Liu, T. Liu, and W.R. Li The TGF-beta1/Smad/CTGF pathway and corpus cavernosum fibrous-muscular alterations in rats with streptozotocin-induced diabetes J. Androl. 33 2012 651 659